Fact Sheets

Acerca de la enfermedad de Parkinson

La enfermedad de Parkinson (EP) es un trastorno neurológico progresivo que afecta el movimiento y otros cambios no motores que impactan la vida diaria. Aunque aún no existe una cura, los tratamientos pueden ayudar a controlar los síntomas y mejorar la calidad de vida.

¿Qué tan común es el Parkinson?

El Parkinson es la segunda enfermedad neurodegenerativa más común después de la enfermedad de Alzheimer. Afecta a más de 10 millones de personas en todo el mundo, incluyendo a cerca de un millón en los Estados Unidos. Cada año, alrededor de 90,000 estadounidenses son diagnosticados con la EP.

¿Cuáles son los síntomas del Parkinson?

El Parkinson afecta a cada persona de manera diferente. Las señales tempranas pueden incluir un temblor leve, pérdida del olfato, voz baja o letra más pequeña.

Los síntomas motores comunes incluyen temblor en una o ambas manos, rigidez, movimientos lentos (llamados bradicinesia) y problemas de equilibrio. Los síntomas no motores, como los problemas del sueño, el estreñimiento, la depresión, la ansiedad y los cambios en el pensamiento, también son frecuentes y pueden afectar la calidad de vida tanto como los síntomas motores.

¿Qué causa el Parkinson?

El Parkinson se desarrolla cuando las células cerebrales que producen dopamina —una sustancia química que regula el movimiento y otras funciones— se dañan y mueren gradualmente. A medida que disminuyen los niveles de dopamina, aparecen los síntomas. Aunque no se conoce la causa exacta, los científicos creen que una combinación de factores genéticos, ambientales y del estilo de vida influye en el desarrollo de la enfermedad.

PD GENEration: Impulsado por la Parkinson's Foundation, es un estudio de investigación mundial y en curso que ofrece pruebas genéticas y consejería genética sin costo para personas con la EP. Los hallazgos actuales muestran que casi el 13% de los participantes tienen un cambio genético (o variante) vinculado al Parkinson.

¿Quiénes están en riesgo de tener Parkinson?

El Parkinson suele diagnosticarse después de los 60 años, aunque alrededor del 4% de las personas son diagnosticadas antes de los 50 años, lo que se conoce como enfermedad de Parkinson de inicio temprano. Los hombres tienen aproximadamente 1.5 veces más probabilidades de desarrollar la EP que las mujeres.

¿Cómo se diagnostica el Parkinson?

El camino hacia el diagnóstico suele comenzar con un médico de cabecera, quien podría recomendar una consulta con un neurólogo si los síntomas sugieren Parkinson. Algunos neurólogos se especializan en la enfermedad de Parkinson y otras afecciones similares. Se les conoce como especialistas en trastornos del movimiento.

No existe una prueba única para el Parkinson. En su lugar, los médicos se apoyan en varias herramientas:

  • Observación clínica: El médico revisa los síntomas, pregunta sobre el historial de salud y observa cómo camina y se mueve la persona.
  • Prueba con medicamentos: Se puede indicar un tratamiento corto de levodopa, un medicamento utilizado para tratar la EP, para ver si los síntomas mejoran.
  • Pruebas de diagnóstico: A veces se necesitan estudios por imágenes para descartar otras afecciones.

¿Cuáles son las opciones de tratamiento para el Parkinson?

Las opciones de tratamiento se centran en controlar los síntomas y mejorar la calidad de vida. Estas suelen incluir medicamentos, ejercicio regular y, en algunos casos, cirugía.

El Parkinson afecta el movimiento y también otras áreas como el habla, el estado de ánimo y el sueño. Por eso es importante un enfoque de equipo. La atención la suele dirigir un neurólogo y puede involucrar a terapeutas físicos, ocupacionales y del habla y el lenguaje, profesionales de la salud mental y otros especialistas. Vivir bien con el Parkinson comienza con recibir la atención y el apoyo adecuados.

Videos & Webinars

Expert Briefing: Living Alone: Home Safety & Management

Parkinson's disease (PD) can impact a person's ability to live safely and independently in their home. This presentation will provide people with Parkinson's disease, their care partners, and health professionals with information and ideas to help them manage home safety problems associated with PD. It will focus primarily on falls but will also address other potential safety problems related to the motor and non-motor aspects of Parkinson's disease. It will cover risk factors for home safety problems and strategies to prevent them.

At the end of this presentation, participants will:

  1. Describe person, activity and environment-related risk factors and contributors to home safety problems associated with Parkinson's disease.
  2. Understand the impact of home safety problems on daily function and quality of life among people with Parkinson's disease.
  3. List potential strategies for managing home safety risks.

Presenter

Erin Foster, PhD, O.T.D., M.S.C.I., O.T.R./L
Assistant Professor, Occupational Therapy, Neurology and Psychiatry
Washington University School of Medicine

This series is made possible by educational grants from AbbVie, Inc., Sunovion and Lundbeck LLC.

The Parkinson's Foundation designs Expert Briefings in collaboration with the Dallas Area Parkinsonism Society (DAPS); the Houston Area Parkinson Society (HAPS); the Michigan Parkinson Foundation (MPF); Northwest Parkinson's Foundation (NWPF); Parkinson Association of the Carolinas (PAC); the Neuro Challenge Foundation (NCF); the Parkinson Association of the Carolinas (PAC); the Parkinson Association of the Rockies (PAR); the Parkinson's Association (PA); and the Parkinson Support Center of Kentuckiana (PSCKY).

Raise Awareness

PD Dementia: An Important Conversation

Nurse resting her hand on the shoulder of her patient

Many people with Parkinson’s disease (PD) experience some degree of cognitive change, such as slowness of memory, changes in thinking, trouble focusing or difficulty finding words. Dementia is a permanent cognitive change that interferes with daily activities and quality of life. Identifying thinking changes early and discussing them with your doctor are the first steps in treating or ruling out PD-related dementia.

This article is based on a Parkinson’s Foundation Expert Briefing Let’s Talk About Dementia presented by Dr. James Leverenz, Director, Lou Ruvo Center for Brain Health at Cleveland Clinic, a Parkinson’s Foundation Center of Excellence.

Slowed movement, tremor and stiffness are some of the visible movement signs of Parkinson's disease. Though not visible, the impact of non-movement symptoms can be even more challenging for people with PD and their loved ones — this includes issues with thinking and memory. While PD-related cognitive change can be mild, between 60 to 80% of people living with PD for 15 years or more can experience disease-related dementia. Awareness of thinking changes can ensure early treatment.

Lewy Body Dementias

In Parkinson’s, the protein alpha-synuclein misfolds and forms clusters in the brain called Lewy bodies. These sticky clusters upset normal brain function. Lewy bodies are strongly linked to PD and dementia.

Nearly 1.5 million Americans are impacted by Lewy body dementias, including those living with:

  • Parkinson’s disease dementia (PDD): diagnosed when significant cognitive decline occurs in someone living with Parkinson’s movement symptoms for a year or more (usually several years).
  • Dementia with Lewy bodies (DLB): diagnosed when cognitive decline occurs before or at the same time as motor symptoms.

Almost 50% of people with Alzheimer's disease also have some Lewy body brain abnormalities. These are frequently seen in both people who live with sporadic and familial forms of Alzheimer's. When these changes go beyond a part of the brain called the amygdala, people often have some of the same symptoms as people living with dementia with Lewy bodies , frequently developing Parkinson's-like motor symptoms. This is known as the Lewy body variant of Alzheimer disease.

Some researchers theorize that Alzheimer's disease may drive clumping of Lewy bodies. New therapies designed to slow Alzheimer's progression could also hold possibility to slow Lewy body development — another reason for the importance of an early and correct diagnosis, and early treatment.

Dementia Signs and Symptoms

In addition to memory, thinking and behavior changes, other symptoms include:

Despite many shared symptoms across Lewy body dementia diseases, people often store and recall information differently, depending on which cognitive disorder they are living with.

Adding and retaining new memories is often difficult for people living with Alzheimer's disease. It may be challenging for someone with Alzheimer's to remember a question or conversation just minutes after, or they may have forgotten events from the previous day. Encoding new information can be an issue. However, if a person experiencing PD thinking changes struggles retrieving a memory, they can often pull it up with a clue or a reminder.

This means people with PD dementia can store memories. Rather than primary encoding difficulty, they often experience retrieval challenges — an executive dysfunction similar to difficulty multitasking or staying on track during conversations.

People with Alzheimer’s disease tend to have less awareness that they are hallucinating. A person with PD dementia or dementia with Lewy bodies can more often recognize that they are experiencing hallucinations. It’s important for the care provider to ask the person experiencing changes “Do you see things?” People with PD-related dementia will often acknowledge that they do see things, are aware the hallucinations are not real and are not bothered by what they see.

Diagnosing Lewy Body Dementias

Ensuring the person living with thinking changes receives the correct diagnosis is important. When diagnosing dementia, a doctor, neurologist or other healthcare expert will look for the ability to retrieve retained memories, early executive dysfunction or multitasking difficulties.

A review of symptoms, medications, medical history and more are also key to an accurate diagnosis. Your doctor will also rule out other medical illnesses — urinary tract infections or pneumonia can be related to sudden confusion and agitation.

Work with your doctor to identify any medications that might impact symptoms. Some medicines can cause or worsen confusion and hallucinations, including:

  • Certain dopamine-boosting medications that ease movement at lower doses but may worsen thinking problems at higher doses
  • Old antipsychotics, such as haloperidol, and anticholinergic (acetylcholine-blocking)
  • Medications, such as trihexyphenydil, sometimes used to treat tremor

Therapies

Medications used in Alzheimer’s disease have benefits in PD dementia, including rivastigmine, donepezil and galantamine. Selective serotonin reuptake inhibitors (SSRIs), used for depression, may also be beneficial.

For people with Parkinson’s experiencing rapid eye movement (REM) sleep behavior disorder, your doctor might recommend the over-the-counter sleep aid melatonin. Clonazepam is frequently used if melatonin is not effective, although it can cause confusion, daytime sleepiness and other side effects.

Cognitive remediation, provided by a neuropsychologist or speech-language pathologist, focuses on strengthening cognition.

Behavior management modifies activities and environments to improve abilities and independence. It includes creating a daily routine, decluttering living spaces, increasing lighting and using assistive tools to reduce confusion.

Exercise, physical activity and social connection can also benefit cognitive health.

On the Horizon

Research is currently underway to better understand dementia and discover disease-specific therapies. Diagnosing and treating the earliest stages of thinking change can ensure early lifestyle adjustments and the best chance for responsive therapy.

Understanding the biological differences behind the development and onset of all Lewy body dementias will be essential to future disease-specific therapies.

Scientists are currently working to standardize testing of blood and body fluids to reveal amassed Lewy body alpha-synuclein. This could serve as an early detection tool for neurodegenerative disorders related to the protein, such as PD.

Biomarkers for the Lewy Body Dementias, a National Institutes of Health-funded study, recently awarded more than $10 million to the Cleveland Clinic to expand the national Dementia with Lewy Bodies Consortium. A collaboration with several Parkinson’s Foundation Centers of Excellence and others, the coalition accelerates research to improve diagnosis and treatment of dementia with Lewy bodies, including Parkinson’s disease dementia.

People who experience rapid eye movement (REM) sleep behavior disorder (RBD) are at risk for developing Lewy body dementias. This risk factor might be another potential early diagnosis clue or cue to begin preventative future preventative therapies as they become available.

Learn More

The Parkinson’s Foundation believes in empowering the Parkinson’s community through education. Learn more about PD and dementia by calling our free Helpline at 1-800-4PD-INFO (1-800-473-4636) or visiting Parkinson’s Foundation resources below.

Podcasts

Episode 9: The Keys to Driving with Parkinson’s

Driving is a complex task involving many physical skills and mental processes. Age, along with a chronic or progressive illness like Parkinson’s, affects these critical driving skills, making a driver less safe on the road. But giving up the keys is an emotionally charged issue. Lissa Kapust created DriveWise, a program that involves a multidisciplinary team of health professionals who do objective assessments of the many skills and mental abilities needed for safe driving.

Released: August 15, 2017

Podcasts

Episode 91: The Newly Diagnosed Experience

When a person shows up in a doctor’s office with symptoms that may be related to Parkinson’s disease (PD), the diagnosis may not be obvious since symptoms often differ from person to person or could be indicative of other conditions. It’s not uncommon for people go from doctor to doctor over months or even years before they get a correct diagnosis. A visit to a movement disorders neurologist may result in a faster PD diagnosis, but unless PD is suspected, that may not be the first medical specialist on someone’s list.

For some, a Parkinson’s diagnosis comes as a relief; an explanation for previously unexplained symptoms. Others may be stunned, struggling with what the future may look like. As you begin processing your emotions, which can be wide-ranging, it’s important to know you are not alone. In this episode, Gretchen Rosswurm describes her experience with getting a PD diagnosis and how she dealt with it. One way was to take advantage of many of the resources of the Parkinson’s Foundation. Gretchen is now the Chair of the People with Parkinson’s Council of the Foundation. Certainly not everyone accepts or approaches a new PD diagnosis in the same way. So Anna Hedges relates some of the questions she has fielded from newly diagnosed callers as a Parkinson’s Foundation Helpline Information Specialist for the past ten years.

Released: October 6, 2020

Raise Awareness

Disease Modification & Stem Cells: Where Are We Now?

🧠 What will you learn in this article?

Learn more about ongoing Parkinson’s disease research that is setting the foundation for new treatments. Highlights include: 

  • Researchers are developing biomarkers and biological measures to detect Parkinson’s earlier, monitor progression and evaluate whether treatments work.
  • Genetics research can inform people of their genetic tie to Parkinson’s and helps connect them with targeted clinical trials and personalized therapies.
  • Emerging treatments include stem cell replacement of dopamine-producing neurons, alpha-synuclein therapies, gut-brain interventions, focused ultrasound and more.
  • Experimental treatments require caution: never pay to take part in a clinical trial.
female scientist viewing a slide under a microscope in lab setting

Researchers are finding new ways to measure how Parkinson’s disease (PD) progresses and how well promising treatments work. These discoveries could help make way for disease-modifying therapies; interventions that may slow, stop or possibly reverse brain changes in Parkinson’s. Learn more about research breakthroughs and where to exercise caution.

This article is based on an Expert Briefing hosted by movement disorders specialist and Parkinson’s Foundation National Medical Advisor, Michael S Okun, MD, director of the Norman Fixel Institute for Neurological Diseases, a Parkinson’s Foundation Center of Excellence.

Discoveries Driving Disease-Modifying Research: Biomarkers, Genetics and More

Parkinson’s is a progressive brain disease that scientists believe involves a mix of environmental and genetic factors. Researchers are beginning to uncover those complex connections and better understand the diversity of the disease as people with Parkinson’s have different genetic ties to PD, symptoms and rate of progression.

Parkinson’s can begin developing sometimes a decade or more before visible symptoms appear. This quiet evolution has historically made it difficult to test therapies early in the course of disease. Researchers were often unable to enroll people in testing for potential therapies until they had developed the movement symptoms used to diagnose Parkinson’s or learned they had a genetic link. 

Research advances are helping scientists uncover who may be at risk, measure disease biology and test therapies in more targeted ways, including:

Biomarkers: The discovery of biomarkers in PD, substances in the body that provide clues about health, is changing the field. Diagnosis still relies on neurological exams, symptom history and response to dopamine therapies, but key PD biomarker tests can support a diagnosis. Researchers are working toward defining Parkinson’s by biology rather than symptoms. Biomarkers could help diagnose PD earlier, track disease progression and show whether treatments are working.

Focusing on alpha-synuclein: Clumps of misfolded alpha-synuclein proteins are linked to brain changes in Parkinson’s. Researchers are exploring ways to reduce alpha-synuclein production, prevent it from misfolding and clumping or to stop its spread.

Genetic studies: Groundbreaking research, such as PD GENEration: Powered by the Parkinson’s Foundation, is having a tremendous impact in detecting genetic variants linked to Parkinson’s. This work is helping people access clinical trials earlier and driving the development of personalized treatments. 

Thanks to the more than 35,000 people who have already joined PD GENEration, the Parkinson’s Foundation has learned that around 13% of people have a Parkinson’s related genetic variant, a big increase from earlier research estimates of 5 to 10%. The ever-growing study is continuing to propel new discoveries.

Active clinical trials that test new therapies are targeting genetic variants identified through PD GENEration testing, such as LRRK2. Clinical studies for therapies targeting a mutated GBA gene, one of the most common genetic risk factors for Parkinson’s, are also underway. 

Stem cell therapies: Research are exploring the potential of using tissue cells that can be transformed into dopamine neurons to address dopamine loss in Parkinson’s. Stem cell studies suggest that this approach may one day help improve PD symptoms. 

Some promising stem cell studies are moving closer to Phase 3 clinical trials, often one of the last steps before a drug manufacturer seeks approval from the U.S. Food and Drug Administration.

Other research areas to watch include:

  • Glucagon-like peptide-1 (GLP-1) receptor agonists. These and similar therapies, initially targeted at weight loss and type 2 diabetes, are being explored for the potential to improve Parkinson’s symptoms.
  • Studies exploring the gut-brain connection in PD. Scientists have discovered that Lewy bodies (clumps of misfolded alpha-synuclein proteins linked to brain disruption in Parkinson’s) can also be found in the gastrointestinal tract of people living with PD. Dietary interventions to alter gut bacteria and change the course of Parkinson’s may be on the horizon.
  • Focused ultrasound is an advanced PD treatment that may lessen motor fluctuations when medications are no longer effective. Low-intensity focused ultrasound, an emerging technique, is being explored to temporarily open the blood-brain barrier to deliver targeted PD trial treatments directly to the brain.
  • Scientists are exploring whether a gene-editing tool called CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) could address PD-related genetic targets.

Exercising Caution

Though hopeful progress is happening in disease-modifying therapies and stem cell research for Parkinson’s, legitimate trials are critical. Dubious and sometimes dangerous offerings have been shut down by the FDA and regulatory agencies all over the world. 

Stem cell tourism, travel to places with little medical or scientific regulation for unverified treatments, can put people at serious health and financial risk.

⚠️Be careful with any trials or experimental treatments that make big promises, skip over risks or ask for payment. Clinical trials do not charge people to take part.  

If you are considering a trial, be sure to ask questions about study protocols and talk with your healthcare team to determine whether it feels like the right fit. These websites can help you learn more about clinical trials for Parkinson’s:

  • Join A Study — a Parkinson’s Foundation webpage that lists ongoing PD research studies.
  • ClinicalTrials.Gov — a public database with active and completed clinical studies in the U.S. and around the world.

Learn More

Building the foundation for a cure is at the heart of the Parkinson's Foundation mission:

Educational Events

Mind, Mood, and Motion

2:00 pm to 4:00 pm PDT
Free
Woman smiling at the edge of a swimming pool while adjusting her goggles.

Join Parkinson’s Resource Organization (PRO), together with the Parkinson’s Foundation, for “Mind, Mood, and Motion,” a free educational symposium for people with Parkinson's and care partners.

Exercise is a powerful tool for managing Parkinson’s disease symptoms at every stage. This program explains how staying active supports movement, mood and thinking—and may even slow disease progression. Participants will learn practical ways to build exercise into daily life for better mobility and overall well-being.

Attendance is free, including light refreshments and parking, but registration is required and seating is limited.

Speaker:

John D. Legge, MD, Eisenhower Medical Associates

Upcoming Events

Fundraising Events

2026 Medtronic Twin Cities Marathon Weekend

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Twin Cities, MN
Educational Events

Making Research Personal: How You Can Advance Parkinson's Research

Virtual ( Zoom )
1:00 pm to 2:00 pm EST
Free
Husband and wife lookin at a tablet while on their porch

Parkinson's research depends on people living with the disease and their care partners. But what does research participation actually look like, and how do you find opportunities that are right for you?

Join us for a practical conversation about the many ways people can contribute to Parkinson's research, from observational studies and genetic research to clinical trials. Learn how researchers use information such as genetics, biomarkers, and lived experiences to drive discoveries and advance precision medicine. We'll also discuss what participation involves, how eligibility works, and how to find research opportunities that match your interests, goals, and circumstances.

Whether you're simply curious about research or ready to get involved, this webinar will help demystify the process and empower you to take the next step.

Speakers

Dr. Andrew Siderwof
Chief of the Movement Disorders Division
Penn Neurology Pennsylvania Hospital                                           

Ignacio Mata
Associate staff at the Genomic Medicine Institute (GMI), part of the Lerner Research Institute (LRI) at the Cleveland Clinic Foundation
Assistant professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Alexandra Gottlieb
Clinical Research Coordinator
Department of Neurology
Beth Israel Deaconess Medical Center
 

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends, and the community.

We want to thank this webinar's sponsor, Genentech, for supporting our mission.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Fundraising Events

2026 Medtronic Twin Cities Marathon Weekend

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Twin Cities, MN
Educational Events

Cumbre para Cuidadores: Cuidar con confianza

Virtual ( Zoom )
1:00 pm to 3:00 pm EST
Gratis
For Care Partners

Regístrese Aquí
Cuidar con confianza: identidad, límites y apoyo

Recorrer el camino del cuidado del Parkinson implica cambios continuos, no solo para la persona con Parkinson, sino también para usted, el cuidador. Este webinar inspirador de dos horas está diseñado para ayudarle a apoyar a su ser querido mientras también cuida de usted mismo con confianza, claridad y compasión.

Acompáñenos en Cuidar con confianza, un encuentro virtual de dos horas creado para apoyar a los cuidadores en cada etapa del camino del Parkinson. Ya sea que apenas esté comenzando a cuidar a un familiar o que haya brindado cuidados durante años, este webinar ofrece orientación práctica, ánimo y la oportunidad de conectarse con otras personas que entienden la experiencia de cuidar.

Escuche a profesionales de la salud hablar sobre cómo cuidar de su propio bienestar mientras apoya a alguien que ama, escuche a cuidadores compartir sus experiencias personales y lecciones aprendidas, y descubra cómo contar historias a través de imágenes puede ayudarle a expresar su experiencia vivida de maneras significativas. A lo largo del programa, también tendrá oportunidades para reflexionar, participar en una pausa de movimiento suave y unirse a una sesión de preguntas y respuestas en vivo, y se irá con estrategias prácticas, ánimo renovado y conexión con su comunidad.

10 a.m. hora del Pacífico (California)
11 a.m. hora de la Montaña (Colorado, Arizona y Nuevo México)
12 p.m. hora del Centro (Texas y Ciudad de México)
1 p.m. hora del Este (Nueva York, Peru y Colombia)
2 p.m. hora de Venezuela
3 p.m. hora de Chile y Argentina
7 p.m. hora de España

*Por favor, verifica su zonas horarias.*

Presentadores

Gilda Gonzalez, MSW LCSW
Trabajadora social clínica licenciada
AdventHealth

Selys Y. Rivera-Reyes, MSW LCSW
Trabajadora social clínica licenciada
AdventHealth

Eric E. Espinoza
Coordinador de programa y alcance comunitario, Programa de enfermedad de Parkinson y trastornos del movimiento
Coordinador de investigación, KTEAM Lab
Shirley Ryan AbilityLab

Panelistas

Maria Flores – Aliado en el cuidado de su esposo con la EP
Myrella Guzman – Aliado en el cuidado de su padre con la EP
Alejandro Rodriguez-Olmos – Aliado en el cuidado de su madre con la EP

¿Busca algo más? Podrá encontrar todos nuestros videos de EP Salud en Casa en YouTube


Más información:

Todos los eventos de “EP Salud en Casa" – Parkinson.org/EPSalud.

Una lista de nuestros recursos en español – Parkinson.org/Recursos

Línea de Ayuda – 1-800-473-4636, opción 3 para español.


La Parkinson’s Foundation agradece a Amneal por patrocinar esta programación.


 

Upcoming Events

Fundraising Events

2026 Medtronic Twin Cities Marathon Weekend

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Twin Cities, MN
Educational Events

Coffee & Conversations: Living Safely and Independently at Home

Virtual ( Zoom )
10:00 am to 11:00 am CDT
FREE
Woman in kitchen

Explore practical ways to make everyday life at home safer, easier and more manageable. We will discuss simple modifications, routines and tools that can support independence and confidence while helping reduce common safety risks.

Program runs from 10 to 11 am Central Time. Join us on your computer or tablet for the best experience and so you can see all slides.

Expert speaker

Michelle Holloway headshot

Michelle Holloway, OTD
Lifestyle Transitions, PLLC

Michelle Holloway, OTD, is an occupational therapist specializing in movement disorders, fall prevention, and functional independence for individuals living with Parkinson’s disease. Through her work, she focuses on supporting individuals and their care partners in navigating daily life with greater structure, awareness, and intention. She is the founder of Lifestyle Transitions, PLLC, a mobile consulting practice specializing in accessible home environments. She is also the author of The Parkinson’s Planner, The Healthcare Journal for the Parkinson’s Planner, and A Companion Journal for the Parkinson’s Planner.


There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family and friends and the community.

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Fundraising Events

2026 Medtronic Twin Cities Marathon Weekend

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Twin Cities, MN
Fundraising Events

2026 St. George, Utah Marathon

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

St. George, UT
Back to Top